German University in Cairo
🇩🇪Germany
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Phase 2
Recruiting
- Conditions
- Rheumatoid Arthritis (RA)
- Interventions
- Drug: CarnitineDrug: Disease-modifying anti-rheumatic drugs
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 60
- Registration Number
- NCT06753565
- Locations
- 🇪🇬
Demerdash hospital, Cairo, Demerdash, Egypt
Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 70
- Registration Number
- NCT06458686
Clinical Evaluation of the Effect of Metformin in Sepsis
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 110
- Registration Number
- NCT05979038
- Locations
- 🇪🇬
Al Demerdash University Hospital, Cairo, Egypt
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Active, not recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Blood sample collection
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 138
- Registration Number
- NCT05735067
- Locations
- 🇪🇬
Nasser Institute for Research and Treatment, Cairo, Egypt
Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients
Phase 2
Completed
- Conditions
- Radiation Dermatitis
- Interventions
- Drug: Baraka CapsulesDrug: Imtenan Oil
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 132
- Registration Number
- NCT05693597
- Locations
- 🇪🇬
Ain Shams University Hospital, Cairo, Egypt
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine
Phase 2
Completed
- Conditions
- Hand and Foot Syndrome
- Interventions
- Drug: (CARBAMIDE®)Drug: (VOLTAREN®) Emulgel 1%
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 86
- Registration Number
- NCT05641246
- Locations
- 🇪🇬
KASR ALAINY Center of Oncology and Nuclear medicine, Cairo, Egypt
Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients
Phase 2
Recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 80
- Registration Number
- NCT05298670
- Locations
- 🇪🇬
Nasser Institute for Research and Treatment, Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath